Artificial Intelligence Blood Test Accelerates Bowel Cancer Detection

A new blood test powered by Artificial Intelligence aims to speed up bowel cancer diagnosis, supported by Cancer Research UK in memory of Dame Deborah James.

A new research initiative, funded by Cancer Research UK, is developing a blood test that utilizes Artificial Intelligence to detect bowel cancer more rapidly. This effort is dedicated to the memory of campaigner Dame Deborah James, reflecting continued advancements in digital health technology for cancer diagnostics.

The research lab aims to harness advanced computational techniques to analyze blood samples and identify early markers associated with bowel cancer. By applying Artificial Intelligence to large sets of patient data, researchers hope to increase the speed and accuracy of diagnoses, potentially allowing for earlier intervention and improved outcomes.

This project signifies growing momentum behind the integration of Artificial Intelligence in medical diagnostics. If successful, the test could reduce the dependence on invasive procedures and enable healthcare providers to identify at-risk patients sooner, improving chances of successful treatment and survival rates for bowel cancer.

75

Impact Score

Executives see agentic artificial intelligence as vital to survival by 2027

Global executives are rapidly pivoting from generative artificial intelligence to agentic artificial intelligence, viewing it as essential to both infrastructure modernization and workforce transformation. A new Cisco and Omdia survey highlights rising urgency around networks, skills and leadership as companies move from pilots to scaled deployment.

Nvidia prepares PC return with Arm and x86 chip collaborations

Nvidia is preparing a return to the consumer PC market through new system-on-a-chip designs built with MediaTek Arm processors and separate x86 efforts tied to Intel, creating a potentially complex, dual-track strategy for Windows devices.

India’s role in pharma’s shift to Artificial Intelligence led platform models

Global pharma is moving from linear drug development to Artificial Intelligence led, platform-based models that tightly integrate discovery, data and manufacturing, opening a strategic window for India to move beyond cost-led scale. India’s opportunity lies in building integrated biopharma systems where science, digital intelligence and modular manufacturing are orchestrated from the outset.

Contact Us

Got questions? Use the form to contact us.

Contact Form

Clicking next sends a verification code to your email. After verifying, you can enter your message.